Physicians' Academy for Cardiovascular Education

Clinical dialogue: Lowering ASCVD risk in a patient with T2DM and obesity

Listen to the podcast
15' education - July 5, 2022 - Prof. Nikolaus Marx, MD (Aachen, Germany) and Adie Viljoen, MD (Stevenage, UK)

Video navigation menu

  • Casus presentation 0:37
  • Treatment plan 3:37
  • EASD/ADA Consensus 2019  6:44
  • Trial results with GLP-1RAs 7:33
  • Benefits with GLP-1RAs 10:12
  • Real-world data and new approaches 12:51
  • Conclusive remarks 15:03


Show transcript


Prof. Nikolaus Marx, Professor of Medicine / Cardiology, Head of Department of Internal Medicine, Cardiology, Angiology, and Intensive Care Medicine, University Hospital Aachen, Germany.

Adie Viljoen, MD is Consultant Chemical Pathologist Metabolic Medicine at the Lister Hospital in Stevenage and Honorary Consultant at Cambridge Universities NHS Trust, UK.


This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.


Funding for this educational program was provided by an unrestricted educational grant received from Novo Nordisk.


This educational activity is intended for an international audience of non-US and non-UK HCPs

The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: